Liberty Gold: Advancing a Multi-Million Ounce Gold Project With Antimony Upside
Liberty Gold is building long-term shareholder value with a large-scale oxide gold project in Idaho and a potential high-grade antimony asset in Utah.
A near-construction oxide gold mine in the Great Basin with added exposure to critical minerals
Why This Matters
Liberty Gold (TSX: LGD, OTCQX: LGDTF) is developing one of the Great Basin’s most significant open-pit gold oxide deposits at a time when U.S. domestic resource supply is under the spotlight. The company’s flagship asset, located in southern Idaho, holds a 5 to 8 million-ounce gold system with a completed prefeasibility study and formal mine permitting process already underway. With its low-cost heap leach model and scalable footprint, the project is on track to support future construction.
Meanwhile, Liberty Gold is creating additional value with the discovery of high-grade antimony mineralization at its second asset in Utah. As global demand grows for antimony, a critical mineral used in munitions and fire retardants, the company plans to spin out this asset into a new entity—offering Liberty shareholders exposure to both gold development and strategic minerals. With strong project economics and infrastructure access, Liberty Gold is positioning itself to be a key U.S. player in both precious and critical metals.
Key Takeaways:
- Flagship oxide gold asset with up to 8 million ounces in southern Idaho
- Low-cost, open-pit heap leach model with robust PFS and permitting underway
- Discovery of high-grade antimony at second site adds critical mineral upside
- Spinout planned for Utah asset, providing Liberty shareholders with added exposure
- Operating in mining-friendly U.S. jurisdictions with clear permitting pathways
For more information on Liberty Gold (TSX: LGD, OTCQX: LGDTF), watch their video HERE
Published by BTV - The Agency
Discover Investment Opportunities with BTV. Delivering engaging content to Investors for 25+ years.
You might also like
.jpeg)
Picard Medical / SynCardia Tackling One of the Largest Unmet Needs in Cardiovascular Medicine
Advanced heart failure continues to rise globally, while the supply of donor hearts remains limited. This structural imbalance creates a significant and expanding market opportunity, with thousands of patients each year lacking viable treatment options and placing growing economic pressure on healthcare systems.
